News

May 4, 2010 — New research released this week in the Journal of the American College of Cardiology shows the value of implantable cardiac device diagnostics in identifying worsening...

March 24, 2010 – Enrollment began this week in the CITADEL, which is the second of two large-scale, prospective, multicenter studies comparing implantable electrophysiology device infection rates...

March 22, 2010 – The FDA’s Circulatory System Devices Panel last week unanimously recommended expanding the indication for cardiac resynchronization therapy defibrillators (CRT-Ds) to slow the...

February 8, 2010 – The FDA cleared the Sorin Paradym CRT Model 8750, a cardiac resynchronization therapy defibrillator (CRT-D), which features a new battery technology that delivers 37 joules, one...

February 5, 2010 – European CE mark approval was granted and first implants reported for the Fortify and Fortify ST implantable cardioverter defibrillators (ICD) and Unify cardiac...

November 9, 2009 – Boston Scientific Corp. today announced the launch of its COGNIS cardiac resynchronization therapy defibrillator (CRT-D) and the TELIGEN implantable cardioverter defibrillator (...

November 9, 2009 – Boston Scientific Corp. said Friday it reached an agreement in principle with the U.S. Department of Justice (DOJ) related to product advisories issued by its Guidant subsidiary...

November 4, 2009 — BIOTRONIK Inc. this week announced the results from site preparation, antibiotic use and infection sub-analysis from the REPLACE Registry.

October 20, 2009 – St. Jude Medical Inc. today said it received European CE mark approval for the industry’s first quadripolar pacing system for cardiac resynchronization therapy defibrillators (...

October 8, 2009 – Boston Scientific Corp. this week announced its exclusive sponsorship and first enrollments of the MADIT-RIT clinical trial, which will determine the best device programming...

September 15, 2009 – Fluid monitoring with OptiVol Fluid Status Monitoring is a more accurate predictor of worsening heart failure compared to daily weight monitoring in heart failure patients...

September 14, 2009 – The 13th Annual Scientific Meeting of the Heart Failure Society of America (HFSA) today featured four late breaking clinical trials at the Hynes Convention Center in Boston....

August 3, 2009 – Circulatory assist pump maker Thoratec Corp. and small implantable blood pump maker HeartWare International Inc. terminated their merger agreement in response to U.S. Federal...

Jul y 21, 2009 – St. Jude Medical Inc. today said the FDA cleared its Accent RF pacemaker and Anthem RF CRT-P (cardiac resynchronization therapy pacemaker). The company also announced FDA and...

July 17, 2009 – Medtronic announced today the first enrollments in a magnetic resonance imaging (MRI) substudy of the global PANORAMA registry.

Dr. Raed Sweidan, consultant...

June 25, 2009 – Today, St. Jude Medical Inc. and Medtronic Inc. both commended the efforts of investigators in the Multicenter Automatic Defibrillator Implantation Trial with Cardiac...

June 23, 2009 - Today, Medtronic Inc. announced the first worldwide enrollments in the MORE-CARE (Monitoring Resynchronization in Cardiac Patients) trial, which will compare two disease management...

May 26, 2009 – Biotronik Inc. recently launched its Lumax 540 series implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillator (CRT-D) devices during Heart...

May 18, 2009 - With electrophysiology procedures continuing to grow in a time of increasing economic constraints, the need for cost-effective clinical systems is acute, and to address this need,...

May 18. 2009 - TYRX Inc. announced the initial, interim clinical results from its AIGISRX Antibacterial Envelope Retrospective Registry during Heart Rhythm 2009 in Boston last week.

May 14, 2009 - St. Jude Medical Inc. yesterday announced European CE mark approval of its Accent RF pacemaker and Anthem RF CRT-P (cardiac resynchronization therapy pacemaker).

May 6, 2009 - Medtronic Inc. today said the FDA approval and availability of the Attain Ability left‐heart lead (Model 4196) for use with cardiac resynchronization therapy (CRT) devices for heart...

April 14, 2009 - Biotronik Inc. announced yesterday the first U.S. implant of the next-generation Lumax 540 Series defibrillator for treating patients with heart failure.

The Lumax 540...

April 3, 2009 - BIOTRONIK GmbH & Co Kg this week announced the global launch of BIOTRONIK Home Monitoring with its intelligent traffic light system, designed to provide efficient and...

April 2, 2009 - The 24-month findings from the REVERSE (Resynchronization Reverse Remodeling in Systolic Left Ventricular Dysfunction) trial, sponsored by Medtronic Inc.

March 19, 2009 – The enrollment phase of the RAFT clinical trial (Resynchronization/Defibrillation for Ambulatory Heart Failure Trial) is complete, announced Medtronic Inc.

February 6, 2009 – The FDA has approved St. Jude Medical Inc.’s medical device system that allows a single defibrillation lead connection between a cardiac resynchronization therapy defibrillator...

December 4, 2008 - Pressure Products Inc. said this week the FDA granted market clearance to distribute the SafeSept transseptal guide wire, to be used in conjunction with a standard Brockenbrough...

December 4, 2008 - St. Jude Medical Inc. this week said it received expanded approval from the Japanese Ministry of Health, Labour and Welfare for the QuickOpt Timing Cycle Optimization feature in...

November 25, 2008 – TYRX Inc. today announced the 1,000th implant of the AIGISRx Antibacterial Envelope following its commercialization in June.

AIGISRx is an antibacterial surgical mesh...

November 14, 2008 - Headphones for MP3 players placed within an inch of pacemakers and implantable cardioverter defibrillators (ICDs) may interfere with these devices, according to research...

November 14, 2008 - Surplus energy generated by the heart may one day help power pacemakers and defibrillators implanted in cardiac patients, according to research presented this week at the...

September 1, 2008 - More than 22 million people worldwide suffer from heart failure, and most heart failure hospitalizations are due to excessive fluid accumulation in the chest cavity, and new...

August 7, 2008 - St. Jude Medical Inc. today said it received regulatory approval, in addition to reimbursement approval, from the Japanese Ministry of Health, Labour and Welfare (MHLW), for the...

June 18, 2008 – Biotronik GmbH launched the Lumax 540 series, which includes implantable cardioverter defibrillators (ICDs) and a cardiac resynchronization therapy defibrillator (CRT-D), which is...

April 29, 2008 - Sorin Group Cardiac Rhythm Management completed the first implant in a clinical trial of its new-generation PARADYM 8770 sonR cardiac resynchronization therapy defibrillator (CRT-...

April 24, 2008 - Boston Scientific Corp. completed enrollment in the Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy (MADIT-CRT), engineered to test...

April 4, 2008 - Medtronic presented data at the ACC on its REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial showed that more patients in the trial...

March 3, 2008 - Boston Scientific Corp. received CE Mark approval of its ACUITY Spiral left ventricular lead for use with cardiac resynchronization therapy defibrillators and cardiac...

February 5, 2008 - Doctors completed the first implant of Boston Scientific’s COGNIS cardiac resynchronization therapy defibrillator (CRT-D), which reportedly represents an entirely new platform...

February 29, 2008 - Physicians began performing the first European implants of the COGNIS cardiac resynchronization therapy defibrillator (CRT-D) and the TELIGEN implantable cardioverter...

February 27, 2008 - Boston Scientific Corp. said the FDA approved three products in its Cardiac Rhythm Management business, including the CONFIENT implantable cardioverter defibrillator (ICD), the...

January 22, 2008 - Boston Scientific Corp. today announced CE Mark approval for its COGNIS cardiac resynchronization therapy defibrillator (CRT-D) and TELIGEN implantable cardioverter...

November 13, 2007- There is significant underutilization of many guideline-indicated life-saving medical and device therapies for heart failure (HF) patients, according to the Registry to Improve...

October 9, 2007 – Medtronic Inc. today announced that it has begun enrolling in the PRECEDE-HF clinical trial that will evaluate Medtronic’s proprietary Cardiac Compass and OptiVol Fluid Status...

July 17, 2007 - St. Jude Medical Inc. today announced that it received regulatory approval from the Japanese Ministry of Health, Labor and Welfare and reimbursement approval for its first CRT-D...